Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen in Non-Muscle Invasive Bladder Cancer
NCT02197897Phase 2Completed
- Sponsor
- Baylor College of Medicine
- Start
- Apr 2015
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tamoxifen in bladder cancer, sponsored by Baylor College of Medicine. Started Apr 2015; status: completed.
02
Drugs
tamoxifen
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT02197897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02197897.